The oncogenic roles of MKK3 were also reported by Yi et al., who showed the L1 cell adhesion molecule (L1CAM)-dependent dysregulation of MKK3-p38MAPK signaling pathway activation in L1CAM highly expressing B16F10 melanoma cells. The gene discussed is MAP2K3; the disease is melanoma.